ArticleCancer management and research2020

Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung Cancer.

Satoshi Igawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.